KESTRA MEDICAL TECHNOLOGIES ($KMTS) posted quarterly earnings results for Q3 2026 on Tuesday, March 17th. The company reported earnings of -$0.61 per share, missing estimates of -$0.61 by $0.00. The company also reported revenue of $24,550,000, beating estimates of $23,319,535 by $1,230,465.
Stock price change since market close: +2.89%
You can see Quiver Quantitative's $KMTS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KESTRA MEDICAL TECHNOLOGIES Insider Trading Activity
KESTRA MEDICAL TECHNOLOGIES insiders have traded $KMTS stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $KMTS stock by insiders over the last 6 months:
- BRIAN DANIEL WEBSTER (See Remarks) has made 0 purchases and 5 sales selling 45,000 shares for an estimated $1,124,890.
- TRACI S UMBERGER (See Remarks) sold 10,500 shares for an estimated $280,200
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
KESTRA MEDICAL TECHNOLOGIES Hedge Fund Activity
We have seen 81 institutional investors add shares of KESTRA MEDICAL TECHNOLOGIES stock to their portfolio, and 29 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,529,851 shares (+137.5%) to their portfolio in Q4 2025, for an estimated $67,091,648
- BAIN CAPITAL INVESTORS LLC removed 1,846,887 shares (-6.8%) from their portfolio in Q4 2025, for an estimated $48,979,443
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,299,391 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $30,873,530
- HOLOCENE ADVISORS, LP removed 782,624 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $20,755,188
- FRANKLIN RESOURCES INC added 612,343 shares (+180.8%) to their portfolio in Q4 2025, for an estimated $16,239,336
- FMR LLC added 573,656 shares (+10.9%) to their portfolio in Q4 2025, for an estimated $15,213,357
- VANGUARD GROUP INC added 522,181 shares (+69.4%) to their portfolio in Q4 2025, for an estimated $13,848,240
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KESTRA MEDICAL TECHNOLOGIES Analyst Ratings
Wall Street analysts have issued reports on $KMTS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 12/12/2025
- BTIG issued a "Buy" rating on 11/18/2025
To track analyst ratings and price targets for KESTRA MEDICAL TECHNOLOGIES, check out Quiver Quantitative's $KMTS forecast page.
KESTRA MEDICAL TECHNOLOGIES Price Targets
Multiple analysts have issued price targets for $KMTS recently. We have seen 4 analysts offer price targets for $KMTS in the last 6 months, with a median target of $29.0.
Here are some recent targets:
- David Roman from Goldman Sachs set a target price of $25.0 on 12/15/2025
- Matt O'Brien from Piper Sandler set a target price of $30.0 on 12/12/2025
- Larry Biegelsen from Wells Fargo set a target price of $28.0 on 12/12/2025
- Marie Thibault from BTIG set a target price of $32.0 on 11/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
